Position in GILD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$13,164,627
-$1,254,174 QoQ
Shares Held
104,200
+0.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#388
of 2,275 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arkadios Wealth Advisors holds $175,268,765 across 14 Drug Manufacturers - General names. GILD ranks #6 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
32,277 | $38,714,004 | |
| 2 | JNJ |
Johnson & Johnson
|
114,657 | $29,119,437 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
320,925 | $18,491,698 | |
| 4 | MRK |
Merck & Co., Inc.
|
140,968 | $18,114,387 | |
| 5 | ABBV |
AbbVie Inc.
|
65,660 | $16,522,681 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
104,200 | $13,164,627 | |
| 7 | PFE |
Pfizer Inc
|
411,666 | $9,912,916 | |
| 8 | AMGN |
Amgen Inc
|
26,885 | $9,735,596 |
All Filings in GILD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,164,627 | 104,200 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $14,418,801 | 103,457 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $5,722,138 | 46,620 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,093,013 | 45,883 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $5,327,413 | 48,051 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $5,126,286 | 45,750 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,171,618 | 23,510 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $2,849,134 | 33,983 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $2,615,687 | 38,124 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $1,971,890 | 26,920 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $2,227,045 | 27,491 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $1,370,427 | 18,287 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $295,255 | 3,831 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $301,595 | 3,635 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $309,145 | 3,601 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $275,815 | 4,471 | Shares | Sole | 2022-10-21 | |
| 2021-09-30 | $174,136 | 2,493 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $125,118 | 1,817 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $38,325 | 593 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $38,859 | 667 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $46,571 | 737 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $143,031 | 1,859 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $127,092 | 1,700 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||